Literature DB >> 7130340

Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women.

C Christiansen, M S Christensen, N E Larsen, I B Transbøl.   

Abstract

Dose-response relationships of estrogen (E) on indices of calcium balance and bone activity were studied in normal early postmenopausal women. Calcium balance was estimated by changes in forearm bone mineral content, measured by photon absorptiometry. Bone activity was estimated by serum alkaline phosphatases (S-aPh), indicating bone formation, and by fasting urinary excretion of hydroxyproline (U-HyPro) and calcium (U-Ca), indicating bone resorption. A total of 92 female volunteers were randomized to 12 months' treatment with placebo or one of three different doses (high, medium, or low) of natural estrogens (17 beta-estradiol and estriol, 4/2, 2/1, and 1/0.5 mg, respectively), sequentially combined with the same dose (1 mg) of norethisterone acetate for 10 of the 28 cycle days. The trial was completed by 79 women. Bone mineral content declined by 2% (P less than 0.001) in the placebo group, remained constant in the low hormone group and increased by 0.8% (P less than 0.05) and 1.5% (P less than 0.01), respectively, in the medium and high hormone groups. S-aPh decreased gradually and equally by 20-25% in the three hormone groups and U-HyPro and U-Ca decreased by 30-40% during 1-yr hormone treatment, irrespective of dose. The decrease in these three indices occurred practically without exceptions. Compared to the values found in 48 normal premenopausal women the untreated postmenopausal women had increased values of S-aPh (P less than 0.001), U-HyPro (P less than 0.01), and U-Ca (P less than 0.001), and no pretreatment values were below the normal premenopausal range. After treatment the mean values of S-aPh and U-HyPro were slightly lower than the premenopausal mean values (P less than 0.01). These data strongly support the major importance of E deficiency for early postmenopausal bone loss, which is prevented by even a small substitution dose of E.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7130340     DOI: 10.1210/jcem-55-6-1124

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  33 in total

Review 1.  The effects of SERMs on the skeleton.

Authors:  J H Tobias
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

2.  Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation.

Authors:  J Chow; J H Tobias; K W Colston; T J Chambers
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

Review 3.  Late prevention of hip fractures with hormone replacement therapy.

Authors:  J C Stevenson
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

Review 4.  Gonadal hormones.

Authors:  J C Stevenson
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 5.  Hormone replacement therapy in the prevention and treatment of osteoporosis.

Authors:  P D Delmas
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 6.  Hormone replacement therapy in the aged. A state of the art review.

Authors:  S Jacobs; T C Hillard
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

7.  Enhanced osteoblast proliferation and collagen gene expression by estradiol.

Authors:  M Ernst; C Schmid; E R Froesch
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

8.  In vivo modulation of murine serum tumour necrosis factor and interleukin-6 levels during endotoxemia by oestrogen agonists and antagonists.

Authors:  S H Zuckerman; N Bryan-Poole; G F Evans; L Short; A L Glasebrook
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

Review 9.  Nandrolone decanoate: pharmacological properties and therapeutic use in osteoporosis.

Authors:  P Geusens
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

10.  Effects of estrogen replacement on insulin-like growth factor I concentrations in serum and bone tissue and on interleukin 1 secretion from spleen macrophages in oophorectomized rats.

Authors:  F Sato; Y Ouchi; A Masuyama; T Nakamura; T Hosoi; Y Okamoto; N Sasaki; M Shiraki; H Orimo
Journal:  Calcif Tissue Int       Date:  1993-08       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.